IL6 and COVID-19: Due to the increase in inflammatory markers in COVID-19 patients, mononuclear MDSC and polymorphonuclear MDSC may indicate a regulatory mechanism to modulate inflammation, since the expansion of MDSC can be mediated by cytokines such as IL-6, an abundant cytokine in COVID-19 (7, 15).